AI-Driven Cardiac Diagnostics Platform
AI-Driven Cardiac Diagnostics Platform
Project profile curated by GlobalReach Link. Applications are reviewed on a rolling basis.
Project Overview
A medical device and health services platform integrating compact ECG monitoring hardware with AI-based diagnostics. The flagship device is a TGA-approved, credit-card-sized ECG reader that connects to mobile apps for instant health profiling. The company provides both B2C and clinical B2B services, including disability and aged care partnerships under the NDIS program.
Project Goals
Skills Needed
Competitive Advantage
– Device approved by TGA (Class 2a)
– Serving both consumers & clinicians with single platform
– AI-based MapDx for disease pattern matching
– Current & future product roadmap includes wearable sensors (ECG3me, OMNIme)
– Registered NDIS provider; partnerships with aged care & disability services
– First of 6 patents to be filed in 2024
Reasons to Invest & Market Opportunity
– Targeting $54B global cardiac monitoring market
– Dual business model: device sales + clinical services
– TGA-certified hardware, strong R&D roadmap (6 patents by 2026)
– NDIS & aged care onboarding underway
– Proven revenue generation from clinical reimbursements (up to $600/session)
1B+ IoT storage units by 2030; €1.07B SAM in 3 verticals; EU/Asia demand
Problem & Solution
- Problem: Cardiovascular disease is the #1 global killer; arrhythmias account for 30% of strokes. Existing tools are bulky or inaccessible.
- Solution: Portable ECG devices integrated with AI diagnostics and cloud platforms; usable by clinicians and individuals at home, post-dialysis, or in rehab settings.
Highlights
- First product (ecgme) on market since Q3 2023
- Revenue-generating clinical use
- In development: ECG3me (3-lead clinical device, 2025)
- In R&D: OMNIme graphene sensors (multi-vital signal tracking, est. 2029)
- Confirmed demand from both pharmacy and fitness channels
- Registered NDIS provider as of August 2024
Exit Strategy
Apply to Join
Applications are reviewed by the GlobalReach coordination team. Only shortlisted experts will be contacted (NDA for documents).
Sign in may be required before submission.
